Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Genitourinary 1CNS 1

Conditions

Leukemia, Myeloid, Acute 874Precursor Cell Lymphoblastic Leukemia-Lymphoma 499Hematologic Neoplasms 462Leukemia, Lymphocytic, Chronic, B-Cell 388Leukemia 328Myelodysplastic Syndromes 324Lymphoma 203Lymphoma, Non-Hodgkin 191Multiple Myeloma 145Leukemia, Myelogenous, Chronic, BCR-ABL Positive 139Recurrence 136Neoplasms 133Leukemia, Myelomonocytic, Chronic 110Burkitt Lymphoma 92Lymphoma, Mantle-Cell 91Lymphoma, Follicular 91Lymphoma, Large B-Cell, Diffuse 88Myeloproliferative Disorders 84Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 81Leukemia, Biphenotypic, Acute 79Lymphoma, B-Cell, Marginal Zone 75Hodgkin Disease 72Lymphoma, B-Cell 64Waldenstrom Macroglobulinemia 54Primary Myelofibrosis 53Leukemia, B-Cell 50Anemia, Refractory, with Excess of Blasts 45Leukemia, Myeloid, Chronic-Phase 40Hematologic Diseases 37Lymphoma, T-Cell 32

Interventions

haloperidol decanoate 1Surveys and Questionnaires 1Lorazepam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Delirium × Other hematologic neoplasm × 1 year × Clear all
NCT01949662 2026-02-13

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
93 enrolled 14 charts
Other hematologic neoplasm

Delirium, Hematologic Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡